Suppr超能文献

血清总甲状腺素和三碘甲状腺原氨酸;格雷夫斯病与甲状腺素替代所致甲状腺素血症的比较。

Total serum thyroxine and triiodothyronine; a comparison between Graves' disease and hyperthyroxinaemia due to thyroxine replacement.

作者信息

Pearce C J, Himsworth R L

出版信息

Acta Endocrinol (Copenh). 1984 Oct;107(2):213-7. doi: 10.1530/acta.0.1070213.

Abstract

Serum concentrations of total thyroxine (T4) and total triiodothyronine (T3) were measured in a group of patients (n = 113) presenting with untreated hyperthyroidism due to Graves' disease and in subjects receiving oral T4 replacement (n = 93) in whom the total T4 concentration was supraphysiological (greater than 150 nmol/l). The mean total T4 concentration in the hyperthyroid group was 226 nmol/l, SD 59, range 151-420, and the mean total T3 concentration was 6.8 nmol/l, SD 2.73, range 3.1-17.5. For the group receiving T4 the mean total T4 concentration was 175 nmol/l, SD 25, range 150-258, and the mean total T3 concentration was 2.66 nmol/l, SD 0.45, range 1.7-4.2. In the hyperthyroid group a highly significant linear correlation was found between total T4 and total T3, T3 = 0.0354 T4 - 1.21, r = 0.761, P much less than 0.001, while in the patients taking T4 this correlation was less close, T3 = 0.0073 T4 + 1.39, r = 0.398, P much less than 0.001. The two groups are readily distinguished by expressing total T4 as a molar ratio of total T3. In the hyperthyroid group the mean T4:T3 ratio was 35.6, SD 7.8, range 19.9-56.1, compared to the patients on T4 where the mean T4:T3 ratio was 67.0, SD 11.7, range 44.3-114 (t = 22.5, P much less than 0.0001). An arbitrarily chosen value of 50 for the T4:T3 ratio affords a simple and convenient means of distinguishing the two categories: in only 3 patients with Graves' disease (2.6%) was the ratio above this, and it was below in only 5 patients (5.4%) taking T4.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

对一组因格雷夫斯病导致未经治疗的甲状腺功能亢进症患者(n = 113)以及一组接受口服T4替代治疗且总T4浓度高于生理水平(大于150 nmol/l)的受试者(n = 93),测量了血清总甲状腺素(T4)和总三碘甲状腺原氨酸(T3)的浓度。甲状腺功能亢进症组的平均总T4浓度为226 nmol/l,标准差为59,范围为151 - 420,平均总T3浓度为6.8 nmol/l,标准差为2.73,范围为3.1 - 17.5。接受T4治疗的组中,平均总T4浓度为175 nmol/l,标准差为25,范围为150 - 258,平均总T3浓度为2.66 nmol/l,标准差为0.45,范围为1.7 - 4.2。在甲状腺功能亢进症组中,总T4与总T3之间存在高度显著的线性相关性,T3 = 0.0354 T4 - 1.21,r = 0.761,P远小于0.001,而在服用T4的患者中,这种相关性较弱,T3 = 0.0073 T4 + 1.39,r = 0.398,P远小于0.001。通过将总T4表示为总T3的摩尔比,可以很容易地区分这两组。甲状腺功能亢进症组的平均T4:T3比值为35.6,标准差为7.8,范围为19.9 - 56.1,而服用T4的患者中,平均T4:T3比值为67.0,标准差为11.7,范围为44.3 - 114(t = 22.5,P远小于0.0001)。任意选择T4:T3比值为50可提供一种简单方便的方法来区分这两类:在格雷夫斯病患者中,只有3例(2.6%)该比值高于此值,而在服用T4的患者中,只有5例(5.4%)该比值低于此值。(摘要截断于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验